To determine whether B1SP can be a potential therapeutic for ER+ breast cancer, we tested the effect on normal mammary epithelial cells, MCF10A, and ER+ breast cancer cells MCF7 and T47D (Figure S6). Here, ESR1 is linked to breast carcinoma.